(18.207.160.209)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2016, Volume : 9, Issue : 5
First page : ( 533) Last page : ( 537)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2016.00100.1

Stability Indicating Validated UPLC Method for Determination of Nebivolol HCl in Bulk and Pharmaceutical Dosage Form

Sujana Kamepalli*, Jagadish P., Venu S., Priyanka T. Pavani

Department of Pharmaceutical Analysis, University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur-522510, Andhra Pradesh, (India)

*Corresponding Author E-mail: sujana_36@yahoo.co.in

Online published on 21 June, 2016.

Abstract

A simple, rapid, precise and accurate stability indicating ultra-performance liquid chromatography method was developed and validated for the quantitative determination of Nebivolol HCl in bulk drug and Pharmaceutical dosage form. Separation was achieved on a Ethylene Bridge Hybrid C18 (2.1 x 50mm, 1.7 μm) column with auto injection system at a detection wavelength of 281nm, using a mobile phase consists of potassium di hydrogen phosphate (25%) and Acetonitrile (75%) in a isocratic elution mode at a flow rate of 0.25mL per min. The detection wavelength of 281 nm for Nebivolol HCl with an injection volume of 5.0μL. The retention time for Nebivolol HCl was found to be 0.5mL per min. The developed UPLC method was validated for selectivity, linearity, accuracy, robustness, precision and specificity as per ICH guidelines. The method also carried for forced degradation studies. The linearity range was found to be 10–50μg/mL for Nebivolol HCl with a correlation coefficient of 0.999. Limit of quantification and Limit of detection was found to be 9.97 and 2.95μV. The method is Precise and Robust and indicated by %RSD. The results were indicating that the method was selective in analysis of Nebivolol HCl in the presence of degradation products under various stress conditions.

Top

Keywords

Nebivolol HCl, Nebicard, UPLC, Degradation studies, ICH Guidelines.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
824,308,037 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.